Loading…
Loading…
MOH does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage, for any covered stock.
TapClick below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
TapClick below to see what's inside, then upgrade to unlock for MOH and 80,000+ other tickers.
See price against where its own fundamentals say it should trade. The shaded gap is the discount or premium, across five valuation lenses.
TapClick below to see what's inside, then upgrade to unlock for MOH and 80,000+ other tickers.
See exactly how MOH's revenue becomes profit: a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for MOH and 80,000+ other tickers.
Molina Healthcare, Inc. offers comprehensive managed health care services, primarily targeting economically disadvantaged families and individuals. The company provides coverage through key government initiatives such as Medicaid and Medicare programs, in addition to state health insurance marketplaces. Its operations are strategically segmented into four main divisions: Medicaid, Medicare, Marketplace, and a general "Other" category. By the close of 2021, specifically December 31st, Molina Healthcare's network extended to approximately 5.2 million members across 18 states, all of whom…
Molina Healthcare NYSE: MOH reaffirmed its full-year 2026 adjusted earnings outlook while outlining preliminary 2027 earnings building blocks exceeding $9.50 per share, supported by anticipated rate increases, the maturation of new contracts and the planned exit from its Medicare Advantage prescription drug business.
Molina Healthcare, Inc. ( MOH ) Q3 2026 Earnings Call October 22, 2026 8:00 AM EDT Company Participants Jeffrey Geyer - Head of Investor Relations Joseph Zubretsky - President, CEO & Director Mark Keim - Senior EVP, CFO & Treasurer Conference Call Participants Andrew Mok - Barclays Bank PLC, Research Division Kevin Fischbeck - BofA Securities, Research Division John Stansel - JPMorgan Chase & Co, Research Division Justin Lake - Wolfe Research, LLC Albert Rice - UBS Investment Bank, Research Division Stephen Baxter - Wells Fargo Securities, LLC, Research Division Scott Fidel - Goldman Sachs Group, Inc., Research Division Sarah James - Cantor Fitzgerald & Co., Research Division David Windley - Jefferies LLC, Research Division Ryan Langston - TD Cowen, Research Division Lance Wilkes - Bernstein Institutional Services LLC, Research Division Michael Ha George Hill - Deutsche Bank AG, Research Division Presentation Operator Good day, and welcome to the Molina Healthcare Third Quarter 2026 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.
Molina (MOH) came out with quarterly earnings of $0.89 per share, beating the Zacks Consensus Estimate of $0.72 per share. This compares to earnings of $1.84 per share a year ago.
While the top- and bottom-line numbers for Molina (MOH) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
LONG BEACH, Calif.--(BUSINESS WIRE)--Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported third quarter 2026 GAAP income per diluted share of $0.73 and adjusted income per diluted share of $0.89. Financial results are summarized below: Three months ended Nine months ended September 30, September 30, 2026 2025 2026 2025 (In millions, except per-share results) Premium Revenue $10,457 $10,841 $30,873 $32,337 Total Revenue $11,082 $11,477 $32,.